Stay updated on Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page.
Latest updates to the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference3%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedSeveral key resources and links related to genetics and clinical trials have been removed, including important URLs from MedlinePlus and DailyMed, which may impact access to critical health information.SummaryDifference5%
- Check23 days agoChange DetectedNew resources related to genetics, cancer treatment, and clinical trials have been added, including links to MedlinePlus and DailyMed for drug information.SummaryDifference0.5%
- Check30 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference4%
- Check37 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.2%
Stay in the know with updates to Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Comb. with Docetaxel in Head & Neck Cancer Clinical Trial page.